145 results
Page 3 of 8
8-K
EX-1.1
zuolzi0
19 Jul 21
Entry into a Material Definitive Agreement
4:15pm
424B5
144nfxv8d7c1xahg
16 Jul 21
Prospectus supplement for primary offering
9:35am
424B5
8u6mzg9tc u2
14 Jul 21
Prospectus supplement for primary offering
5:19pm
8-K
EX-10.3
kr6ljacrw 1vei
14 Jun 21
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.4
cl7xxdbxtmw6f0cmx
14 Jun 21
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
yfz0 xd7lj0
4 Jan 21
Entry into a Material Definitive Agreement
6:03am
424B5
nic3cigmu72odk9s
29 Dec 20
Prospectus supplement for primary offering
4:31pm
8-K
EX-10.2
6k5il32 yso6iaoumf
20 Oct 20
EIB Provides Immunic With up to €24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy
7:19am
8-K
EX-10.1
ubem 7o9p
20 Oct 20
EIB Provides Immunic With up to €24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy
7:19am
8-K
EX-1.1
wr818 0lnc5g9awsc3lg
10 Aug 20
Entry into a Material Definitive Agreement
12:00am
424B5
87lm3keuyq7hge
4 Aug 20
Prospectus supplement for primary offering
10:28am
424B5
x3q g8sest7
3 Aug 20
Prospectus supplement for primary offering
4:30pm